$CTMX hilarious price action. From press release, it was obvious partial responses were seen in pancreatic cancer and not yet in other cancers. Those partial responses are ongoing. Yet after a waterfall plot is shown market is newly skittish ?
Message in reply to: CTMX—(-37%/AH)—My reading of the PR is that they had only 2 partial responses among 51 enrolled patients in all cancer types. The PR obfuscates, but it didn’t fool investors, evidently.